Article
- Author:
- Jashin J. Wu, MD
Publish date: January 11, 2023
Although there have been numerous changes to the dermatology interview process due to the COVID-19 pandemic, the overall fill rate for postgraduate...
Article
- Author:
- Jashin J. Wu, MD
Publish date: October 5, 2022
We sought to characterize national utilization of brodalumab among Medicare beneficiaries by surveying the Medicare Part D Prescriber dataset.
Article
- Author:
- Jashin J. Wu, MD
Publish date: August 10, 2022
Generalized pustular psoriasis (GPP) is a rare severe variant of psoriasis that is characterized by the abrupt widespread onset of small pustules a...
Article
- Author:
- Jashin J. Wu, MD
Publish date: August 10, 2022
Dermatologists should base the selection of an appropriate topical medication on factors including adverse effects, potency, vehicle, and anatomic ...
Article
- Author:
- Jashin J. Wu, MD
Publish date: March 3, 2022
In this editorial, we focus on recent trials of JAK inhibitors tested in patients with atopic dermatitis, including topical RUX, as well as oral ab...
Article
- Author:
- Jashin J. Wu, MD
Publish date: September 7, 2021
We conducted a cross-sectional study to examine the quality of YouTube videos on oral therapies for atopic dermatitis, such as cyclosporine, methot...
Article
- Author:
- Jashin J. Wu, MD
Publish date: September 7, 2021
We performed a cross-sectional study to analyze YouTube videos about topical treatments for atopic dermatitis.
Article
- Author:
- Jashin J. Wu, MD
Publish date: August 19, 2021
In April 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a set of guidelines regarding the man...
Article
- Author:
- Jashin J. Wu, MD
Publish date: August 19, 2021
This article aims to provide clinicians with up-to-date knowledge on biologic performance focusing on skin disease clearance, time to skin disease ...
Article
- Author:
- Jashin J. Wu, MD
Publish date: February 3, 2021
Home phototherapy is a safe and effective option for patients with psoriasis during the coronavirus disease 2019 (COVID-19) pandemic.
Article
- Author:
- Jashin J. Wu, MD
Publish date: February 3, 2021
This review addresses dosing, efficacy, toxicity, drug-related interactions, and contraindications alongside evidence-based treatment recommendatio...
Article
- Author:
- Jashin J. Wu, MD
Publish date: November 5, 2020
In November 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released their recommendations regarding ma...
Article
- Author:
- Jashin J. Wu, MD
Publish date: November 4, 2020
Dermatologists should utilize social media as a platform to post unbiased, evidence-based information regarding manifestations of COVID-19 and guid...
Article
- Author:
- Jashin J. Wu, MD
Publish date: October 13, 2020
The authors sought to synthesize and review the current evidence on risks for deep fungal infections during biologic therapy in patients with psori...
Article
- Author:
- Jashin J. Wu, MD
Publish date: August 12, 2020
This article aims to address updates on recent clinical trial findings (April 2019 to April 2020) regarding biologic therapy initiation and mainten...
